These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38833946)

  • 1. Dan-Lou tablets reduce inflammatory response by inhibiting the activation of NLRP3 inflammasome for coronary heart disease.
    Gao S; He Y; Liu Y; Yu L; Cheng Q; Wang S; Li L; Cui Y; Yu C; Li Z
    Phytomedicine; 2024 Aug; 131():155773. PubMed ID: 38833946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory and antioxidative effects of Dan-Lou tablets in the treatment of coronary heart disease revealed by metabolomics integrated with molecular mechanism studies.
    Li Z; Yang L; Liu Y; Xu H; Wang S; Liu Y; Zhao H; Xie J; Gao S; Gao S; Xu Y; Li L; Li Y; Yu C
    J Ethnopharmacol; 2019 Aug; 240():111911. PubMed ID: 31034953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.
    Su Q; Li L; Sun Y; Yang H; Ye Z; Zhao J
    Cell Physiol Biochem; 2018; 47(4):1497-1508. PubMed ID: 29940584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effect of up-regulated microRNA-221-3p on coronary heart disease via suppressing NLRP3/ASC/pro-caspase-1 inflammasome pathway activation.
    Rong J; Xu J; Liu Q; Xu J; Mou T; Zhang X; Chi H; Zhou H
    Cell Cycle; 2020 Jun; 19(12):1478-1491. PubMed ID: 32372677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dan-Lou tablets reduces inflammatory response via suppression of the MyD88/p38 MAPK/NF-κB signaling pathway in RAW 264.7 macrophages induced by ox-LDL.
    Li Z; Cheng Q; Yu L; He YY; Gao LN; Wang Y; Li L; Cui YL; Gao S; Yu CQ
    J Ethnopharmacol; 2022 Nov; 298():115600. PubMed ID: 35970313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
    Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
    Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
    Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
    Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of mitochondrial homeostasis is responsible for the ameliorative effects of Suhuang antitussive capsule on non-resolving inflammation via inhibition of NF-κB signaling and NLRP3 inflammasome activation.
    Qin W; Tong X; Liang R; Tang K; Wu X; Jia Y; Tan N
    J Ethnopharmacol; 2021 May; 271():113827. PubMed ID: 33460751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ethanolic extract of Artemisia anomala exerts anti-inflammatory effects via inhibition of NLRP3 inflammasome.
    Hong F; Zhao M; Xue LL; Ma X; Liu L; Cai XY; Zhang RJ; Li N; Wang L; Ni HF; Wu WS; Ye HY; Chen LJ
    Phytomedicine; 2022 Jul; 102():154163. PubMed ID: 35597027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine Alleviates Sympathetic Innervation by Inhibiting NLRP3 Inflammasome in Postinfarcted Rats.
    Lee CC; Chen WT; Chen SY; Lee TM
    J Cardiovasc Pharmacol; 2021 Apr; 77(6):745-755. PubMed ID: 34057159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
    Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
    J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats.
    Saber S; Youssef ME; Sharaf H; Amin NA; El-Shedody R; Aboutouk FH; El-Galeel YA; El-Hefnawy A; Shabaka D; Khalifa A; Saleh RA; Osama D; El-Zoghby G; Gobba NA
    Life Sci; 2021 Apr; 270():119123. PubMed ID: 33548287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes.
    Kong F; Ye B; Lin L; Cai X; Huang W; Huang Z
    Biomed Pharmacother; 2016 Aug; 82():167-72. PubMed ID: 27470352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil inhibits TLR4/MyD88/NF-κB/NLRP3 signaling pathway to reduce pyroptosis in rats with myocardial infarction.
    Chen F; Chen ZQ; Zhong GL; Zhu JJ
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1938-1947. PubMed ID: 34034564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection.
    Segovia J; Sabbah A; Mgbemena V; Tsai SY; Chang TH; Berton MT; Morris IR; Allen IC; Ting JP; Bose S
    PLoS One; 2012; 7(1):e29695. PubMed ID: 22295065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
    Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
    PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
    Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
    Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.